Journal article
Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids
Abstract
BACKGROUND: A recent case-controlled study reported an increased risk of diabetes mellitus in patients treated with inhaled corticosteroids for asthma or COPD, versus age-matched controls.
OBJECTIVE: The purpose of the current study was to evaluate whether there was an increased risk of new onset diabetes mellitus or hyperglycaemia among patients with asthma or COPD treated with inhaled corticosteroids.
Authors
O'Byrne PM; Rennard S; Gerstein H; Radner F; Peterson S; Lindberg B; Carlsson L-G; Sin DD
Journal
Respiratory Medicine, Vol. 106, No. 11, pp. 1487–1493
Publisher
Elsevier
Publication Date
November 2012
DOI
10.1016/j.rmed.2012.07.011
ISSN
0954-6111
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Administration, InhalationAdrenal Cortex HormonesAdultAndrostadienesAnti-Asthmatic AgentsAsthmaBudesonideDiabetes MellitusDouble-Blind MethodEthanolaminesFluticasoneFormoterol FumarateHumansHyperglycemiaPulmonary Disease, Chronic ObstructiveRandomized Controlled Trials as TopicRetrospective StudiesRisk Factors